Skip to main content
Go to the University of Minnesota Twin Cities home page
One Stop
MyU
Search
Research & Innovation Office
Office of Biotechnology Activities Oversight
Contact Us
Menu
About Us
Office of Biotechnology Activities Oversight
Contact Us
eProtocol
Research Oversight Areas
Institutional Biosafety Committee (IBC)
Stem Cell Research Oversight (SCRO)
Clinical Trials and the IBC
Fetal Tissue Research (FTR)
Dangerous Gain of Function (dGOF)
Dangerous Gain of Function (dGOF) Overview
Institutional Biosafety Committee
IBC Oversight
IBC Application Process & General Info
General Recommendations
Minimal Risk Application Guidelines
New IBC Protocols & Renewals
IBC Applications for Teaching Laboratories
Amendments to IBC Applications
Annual Continuing Reviews
Post Submission Process
Post Review Process
Post Approval Process
Risk Assessment & Biosafety Containment Levels
IBC Guidance for Core Facilities
Shipment of r/sNA Contained in Organisms or Viral Genomes
Poliovirus Containment
IBC Meeting & Submission Deadlines
Application Sections
Personnel Information
Activities Include
Funding
Study Objectives
r/sNA
Biological Toxins
Infectious Agents
Human Clinical Trials
Genetic Modification of Animals
Safety
Attachments
Assurance
Check for Completeness
Submit Form
IBC Committee
IBC Policies
Incident Reporting
Training & Education
IBC Training & Educational Resources
Stem Cell Research Oversight (SCRO)
Human Gene Transfer (HGT)
Dual Use Research for Concern (DURC)
Fetal Tissue Research (FTR)
Breadcrumb
OBAO
IBC Application Process & General Info
IBC Application Process & General Info
IBC Application Process & General Info
About Us
Office of Biotechnology Activities Oversight
Contact Us
eProtocol
Research Oversight Areas
Institutional Biosafety Committee (IBC)
Stem Cell Research Oversight (SCRO)
Clinical Trials and the IBC
Fetal Tissue Research (FTR)
Dangerous Gain of Function (dGOF)
Dangerous Gain of Function (dGOF) Overview
Institutional Biosafety Committee
IBC Oversight
IBC Application Process & General Info
General Recommendations
Minimal Risk Application Guidelines
New IBC Protocols & Renewals
IBC Applications for Teaching Laboratories
Amendments to IBC Applications
Annual Continuing Reviews
Post Submission Process
Post Review Process
Post Approval Process
Risk Assessment & Biosafety Containment Levels
IBC Guidance for Core Facilities
Shipment of r/sNA Contained in Organisms or Viral Genomes
Poliovirus Containment
IBC Meeting & Submission Deadlines
Application Sections
Personnel Information
Activities Include
Funding
Study Objectives
r/sNA
Biological Toxins
Infectious Agents
Human Clinical Trials
Genetic Modification of Animals
Safety
Attachments
Assurance
Check for Completeness
Submit Form
IBC Committee
IBC Policies
Incident Reporting
Training & Education
IBC Training & Educational Resources
Stem Cell Research Oversight (SCRO)
Human Gene Transfer (HGT)
Dual Use Research for Concern (DURC)
Fetal Tissue Research (FTR)